Passa al contenuto
Merck

Treatment of pediatric anxiety disorders.

Annals of the New York Academy of Sciences (2013-11-28)
Amy Rapp, Alice Dodds, John T Walkup, Moira Rynn
ABSTRACT

This article provides a brief review of the current available data concerning present treatment and potential new treatment advances for pediatric anxiety disorders, such as generalized anxiety disorder, separation anxiety disorder, social phobia, obsessive-compulsive disorder, and posttraumatic stress disorder. Disorder-specific treatment methods and innovations, particularly computer-assisted methods of delivery for cognitive behavioral therapy (CBT) will be reviewed. Additionally, the paper will discuss novel psychopharmacological compounds (e.g., D-cycloserine, riluzole, memantine, and anticonvulsant medications). Available evidence for the efficacy of novel medication strategies in adult studies and implications for their use in pediatrics will be discussed.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
D-Cycloserine
Sigma-Aldrich
D-Cycloserine
Sigma-Aldrich
Riluzole, solid
Sigma-Aldrich
D-Cycloserine, synthetic